Asia
North China Pharma Gets China Nod for Kidney Anemia Drug
North China Pharmaceutical (SHA:600812) obtained drug registration from China's medical products regulator for its roxadustat tablets.The drug is used to treat renal anemia caused by chronic kidney disease, according to a weekend filing with the Shanghai bourse.Shares of the pharmaceutical company closed 1% lower Monday.
SHA:600812